Interv Akut Kardiol. 2021;20(1):18-20 | DOI: 10.36290/kar.2021.005

Arrhythmias in acute and post-myocardial infarction patients

Vít Gloger
Kardiologické oddělení, Krajská nemocnice T. Bati, a. s., Zlín

Arrhythmias are the most frequent complication of myocardial infarction. This review summarizes the up-to-date management of the most common arrhythmias in acute and post-myocardial infarction patients.

Keywords: atrial fibrillation, bradycardia, myocardial infarction, ventricular tachycardia.

Received: December 15, 2020; Revised: February 5, 2021; Accepted: February 5, 2021; Prepublished online: February 5, 2021; Published: April 29, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gloger V. Arrhythmias in acute and post-myocardial infarction patients. Interv Akut Kardiol. 2021;20(1):18-20. doi: 10.36290/kar.2021.005.
Download citation

References

  1. Bougouin W, Marijon E, Puymirat E, et al. Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry. Eur Heart J. 2014; 35(2): 116-122. Go to original source... Go to PubMed...
  2. Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EuroIntervention 2015; 10(9): 1095-108. Go to original source... Go to PubMed...
  3. Avezum A, Piegas LS, Goldberg RJ, et al. Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes. Am J Cardiol. 2008; 102(12): 1577-1582. Go to original source... Go to PubMed...
  4. Soar J, Nolan JP, Böttiger BW, et al. Adult advanced life support section Collaborators. European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation 2015; 95: 100-47. Go to original source... Go to PubMed...
  5. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: European Heart Journal 2015; 41(36): 2793-2867. Go to original source... Go to PubMed...
  6. Meng L, Tseng CH, Shivkumar K, et al. Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review. JACC Clin Electrophysiol. 2017; 3(9): 942-949. Go to original source... Go to PubMed...
  7. Piccini JP, White JA, Mehta RH, et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation 2012; 126(1): 41-49. Go to original source... Go to PubMed...
  8. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351(24): 2481-2488. Go to original source... Go to PubMed...
  9. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009; 361(15): 1427-1436. Go to original source... Go to PubMed...
  10. Zaman S, Narayan A, Thiagalingam A. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. Circulation 2014; 129(8): 848-854. Go to original source... Go to PubMed...
  11. Gatzoulis KA, Tsiachris D, Arsenos P, et al. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. Eur Heart J. 2019; 40(35): 2940-2949. Go to original source... Go to PubMed...
  12. González-Pacheco H, Márquez MF, Arias-Mendoza A, et al. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. J Cardiol. 2015; 66(2): 148-54. Go to original source... Go to PubMed...
  13. Garg L, Agrawal S, Agarwal M, et al. Influence of Atrial Fibrillation on Outcomes in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2018; 121(6): 684-689. Go to original source... Go to PubMed...
  14. Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009; 30(9): 1038-1045. Go to original source... Go to PubMed...
  15. Levy B, Clere-Jehl R, Legras A, et al. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2018; 72(2): 173-182. Go to original source... Go to PubMed...
  16. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020 Aug 29:ehaa612. doi: 10.1093/eurheartj/ehaa612. Epub ahead of print. Go to original source... Go to PubMed...
  17. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119-177. Go to original source... Go to PubMed...
  18. Chen A, Ashburn MA. Cardiac Effects of Opioid Therapy. Pain Med. 2015; 16(Suppl. 1): S27-S31. Go to original source... Go to PubMed...
  19. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013; 34(29): 2281-2329. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.